ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 45 filers reported holding ADICET BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $2,091,000 | -81.6% | 143,214 | -74.9% | 0.38% | -74.5% |
Q1 2022 | $11,373,000 | -4.0% | 569,448 | -15.9% | 1.50% | -15.3% |
Q4 2021 | $11,848,000 | +285.1% | 677,418 | +72.6% | 1.76% | +713.4% |
Q3 2021 | $3,077,000 | +138.3% | 392,418 | +212.6% | 0.22% | +108.7% |
Q2 2021 | $1,291,000 | -27.0% | 125,544 | -7.1% | 0.10% | +73.3% |
Q1 2021 | $1,768,000 | -27.8% | 135,094 | -22.5% | 0.06% | -44.4% |
Q4 2020 | $2,449,000 | -24.9% | 174,277 | -36.5% | 0.11% | -54.2% |
Q3 2020 | $3,261,000 | – | 274,277 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 728,944 | $998,653 | 0.37% |
DAFNA Capital Management LLC | 797,054 | $1,091,964 | 0.34% |
COWEN AND COMPANY, LLC | 2,715,278 | $3,719,930 | 0.26% |
Orbimed Advisors | 8,322,140 | $11,401,332 | 0.24% |
TANG CAPITAL MANAGEMENT LLC | 1,226,352 | $1,680,102 | 0.24% |
Carlyle Group Inc. | 2,115,385 | $2,876,924 | 0.12% |
RTW INVESTMENTS, LP | 4,241,472 | $5,810,817 | 0.12% |
Acuitas Investments, LLC | 136,779 | $187,387 | 0.11% |
Decheng Capital Management III (Cayman), LLC | 200,201 | $274,275 | 0.09% |
GSA CAPITAL PARTNERS LLP | 142,168 | $195 | 0.02% |